A study of quetiapine: Efficacy and tolerability in psychotic adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 11, Issue 4, 2001, Pages 415-424

  Shaw, Jon A ^a   Lewis, John E ^a   Pascal, Shlomo ^a   Sharma, Rakesh K ^a   Rodriguez, Rosemarie A ^a   Guillen, Ramiro ^a   Pupo Guillen, Marilyn ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PROLACTIN; QUETIAPINE;

ADOLESCENT; AGITATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; MALE; OPHTHALMOLOGY; PROLACTIN BLOOD LEVEL; PSYCHOSIS; SOMNOLENCE; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; AGE FACTORS; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DYSSOMNIAS; FEMALE; HEADACHE; HUMANS; MALE; PILOT PROJECTS; PSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0035706262     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454601317261591     Document Type: Article

References (43)

1. Risperidone in adolescents with schizophrenia: An open pilot study
2. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
3. A rating scale for drug-induced akathisia
4. ICI 204, 636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients the schizophrenia
5. Attenuation of anti-psychotic induced hyperprolactemia with clozapine
6. Antipsychotic standard of care: Redefining the definition of atypical antipsychotics
7. Hormonal side effects in women: Typical versus atypical antipsychotic treatment
8. Use of risperidone in pervasive developmental disorders: A case series
9. Review of quetiapine side effects
10. Tardive dyskinesia with quetiapine
11. Quetiapine furmarate (seroquel): A new atypical antipsychotic
12. Risperidone in the treatment of children and adolescents with schizophrenia: A retrospective study
13. Case study: Risperidone treatment of children and adolescents with developmental disorders
14. Quetiapine in adolescent psychosis
15. New atypical antipsychotic medications
16. Weight changes in patients treated with quetiapine
17. The new antipsychotics
18. Positive and Negative Syndrome Scale (PANSS) for schizophrenia
19. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility and suicidality in patients with schizophrenia
20. Novel antipsychotic medications in the treatment of children and adolescents
21. Open-label quetiapine in the treatment of children and adolescents with autistic disorder
22. Significance test for sphericity of a normal n-variate distribution
23. Quetiapine does not elevate prolactin in adolescents with psychotic disorders
24. Pharmacokinetcs, tolerability, and clinical effectiveness of quetiapine fumarate: An open-label trial in adolescents with psychotic disorders
25. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate in adolescents with selected psychotic disorders
26. Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders
27. The Brief Psychiatric Rating Scale
28. Rating scales and assessment instruments for use in pediatric psychopharmacology research: Clinical Global Impression (CGI) scale
29. Quetiapine in neuroleptic-dependent mood disorders
30. Quetiapine for refractory mania in a child
31. Risperidone for young children with mood disorders and aggressive behavior
32. Treatment and outcomes in adolescents with schizophrenia
33. A rating scale for extrapyramidal side effects
34. Quetiapine in patients with schizophrenia: A high and low dose double blind comparison with placebo
35. Risperidone in childhood schizophrenia
36. Quetiapine for refractory schizophrenia
37. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine and haloperidol
38. Use of atypical neuroleptics in child and adolescent psychiatry
39. A rating scale for mania